SANOFI PASTEUR INC. holds $3.7B across 396 federal awards, concentrated at Department of Health and Human Services (HHS). Recompete timing centers on the Sep 4, 2028 PoP end — agencies typically plan 12–18 months ahead.
TO CONDUCT A CLINICAL TRIAL TO ASSESS THE SAFETY, IMMUNOGENICITY, ANTIGEN DOSE, OF MATRIX-M ADJUVANT IN COMBINATION WITH U.S. DOMESTICALLY MANUFACTURED, EGG-BASED A/ASTRAKHAN/3212/2020 (H5N8) INFLUENZA VIRUS VACCINE IN HEALTHY ADULTS AND OLDER ADULTS
Current PoP ends Sep 4, 2028 (770 days remaining). Agencies typically plan 12–18 months ahead — capture window opens around Mar 4, 2027.
Track recompete timing in SCOUT →SANOFI PASTEUR INC. — $3.7B obligated across 396 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Live Demand-Fit + Displacement scoring, alerts on verdict flips, and watchlists. Free — no card required.
See all live recompete landscapes — who else is expiring, and where the openings are.
Open SANOFI PASTEUR INC.’s federal contract profile — agency mix, recompete pipeline, and teaming relationships.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Register free to start exploring SCOUT →